Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
48.25
+1.33 (2.83%)
Jun 3, 2026, 11:34 AM EDT - Market open
KNSA Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 754.05 | 677.56 | 423.24 | 270.26 | 220.18 | 38.54 | |
Revenue Growth (YoY) | 56.71% | 60.09% | 56.61% | 22.75% | 471.24% | - |
Cost of Revenue | 80.6 | 77.67 | 60.91 | 33.41 | 22.9 | 9.1 |
Gross Profit | 673.44 | 599.89 | 362.33 | 236.85 | 197.29 | 29.44 |
Selling, General & Admin | 213.89 | 196.27 | 168.01 | 129.43 | 97.95 | 85.95 |
Research & Development | 105 | 96.85 | 111.62 | 76.1 | 65.49 | 99.3 |
Other Operating Expenses | 261.33 | 229.55 | 128.31 | 56.52 | 24.07 | 0.84 |
Total Operating Expenses | 580.23 | 522.67 | 407.95 | 262.05 | 187.51 | 186.08 |
Operating Income | 93.22 | 77.22 | -45.62 | -25.2 | 9.77 | -156.64 |
Total Non-Operating Income (Expense) | 12.77 | 11.65 | 9.46 | 8.54 | 1.25 | 0.1 |
Pretax Income | 105.98 | 88.87 | -36.15 | -16.65 | 11.03 | -156.54 |
Provision for Income Taxes | -32.93 | -29.86 | -7.04 | 30.74 | 172.34 | -1.39 |
Net Income | 73.06 | 59.01 | -43.19 | 14.08 | 183.36 | -157.92 |
Net Income to Common | 73.06 | 59.01 | -43.19 | 14.08 | 183.36 | -157.92 |
Net Income Growth | - | - | - | -92.32% | - | - |
Shares Outstanding (Basic) | 75 | 74 | 71 | 70 | 69 | 69 |
Shares Outstanding (Diluted) | 80 | 79 | 71 | 72 | 70 | 69 |
Shares Change (YoY) | 10.56% | 10.58% | -0.69% | 2.13% | 2.69% | 10.89% |
EPS (Basic) | 0.98 | 0.80 | -0.60 | 0.20 | 2.64 | -2.30 |
EPS (Diluted) | 0.90 | 0.75 | -0.60 | 0.20 | 2.60 | -2.30 |
EPS Growth | - | - | - | -92.31% | - | - |
Shares Outstanding | 76.69 | 76.29 | 72.52 | 70.46 | 69.7 | 69.06 |
Free Cash Flow | 164.23 | 136.42 | 25.41 | 13.17 | 5.7 | -126.71 |
Free Cash Flow Growth | 20.39% | 436.82% | 92.94% | 130.99% | - | - |
Free Cash Flow Per Share | 2.04 | 1.73 | 0.36 | 0.18 | 0.08 | -1.85 |
Gross Margin | 89.31% | 88.54% | 85.61% | 87.64% | 89.60% | 76.39% |
Operating Margin | 12.36% | 11.40% | -10.78% | -9.32% | 4.44% | -406.38% |
Profit Margin | 9.69% | 8.71% | -10.21% | 5.21% | 83.28% | -409.72% |
FCF Margin | 21.78% | 20.13% | 6.00% | 4.87% | 2.59% | -328.75% |
EBITDA | 94.89 | 78.78 | -43.92 | -22.86 | 12.18 | -154.28 |
EBITDA Margin | 12.58% | 11.63% | -10.38% | -8.46% | 5.53% | -400.27% |
EBIT | 93.22 | 77.22 | -45.62 | -25.2 | 9.77 | -156.64 |
EBIT Margin | 12.36% | 11.40% | -10.78% | -9.32% | 4.44% | -406.38% |
Effective Tax Rate | -31.07% | -33.60% | 19.48% | -184.58% | 1563.01% | 0.88% |